Correction: scFv-based biologics in diabetes: from therapeutic potential to clinical prospects - Summary - MDSpire

Correction: scFv-based biologics in diabetes: from therapeutic potential to clinical prospects

  • By

  • Shikun Ge

  • Luoxuan Wang

  • Yichen Huang

  • Huaizu Guo

  • Fuyao Wei

  • Pan Li

  • Siyuan Li

  • Qian Liu

  • Jin Xu

  • Yilei Xiao

  • Alberto Carlos Piress Dias

  • Lusha Ji

  • July 13, 2026

Share

Objective:

To correct errors in author affiliations and conflict of interest statements in the original article.

Approach:
  • Affiliation Corrections: Multiple author affiliations were corrected to accurately reflect their respective institutions.
  • Conflict of Interest Statement: The conflict of interest statement was updated to clarify the employment of author JX and the absence of other conflicts.
  • Corresponding Author Correction: The corresponding author was corrected from Shikun Ge to Lusha Ji.
  • Reference Correction: A reference citation was corrected for accuracy.
Key Findings:
  • Multiple author affiliations were corrected to accurately reflect their respective institutions.
  • The conflict of interest statement was updated to clarify the employment of author JX and the absence of other conflicts.
  • The corresponding author was corrected from Shikun Ge to Lusha Ji.
Interpretation:

The corrections ensure the integrity and accuracy of the authorship and affiliations in the publication.

Conclusion:

The original version of the article has been updated to reflect these corrections.

Sources:

Original Source(s)

Related Content